Imhotef Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 7.18 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 M
- Revenue Growth 32.14%
- Profit Growth 55.92%
- Ebitda 47.90%
- Net Worth 37.61%
- Total Assets 87.76%
About Imhotef Pharmaceuticals
Imhotef Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 June 2014 and has a history of Ten years and seven months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.18 M.
The company currently has active open charges totaling ₹1.30 M.
Raja Gajendran and Rajaa Vimala serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U52310TN2014PTC096165
-
Company No.
096165
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Jun 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Imhotef Pharmaceuticals Private Limited offer?
Imhotef Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Dry Syrups, Respiratory System Drugs, Anti Asthma Drug, Antibiotic Tablets & Capsules, Cefixime Tablet, Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet, Antipyretic Medication, Paracetamol Tablets.
Who are the key members and board of directors at Imhotef Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raja Gajendran
|
Director | 13-Jun-2014 | Current |
|
Rajaa Vimala
|
Director | 13-Jun-2014 | Current |
Financial Performance of Imhotef Pharmaceuticals.
Imhotef Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.14% increase. The company also saw a substantial improvement in profitability, with a 55.92% increase in profit. The company's net worth Soared by an impressive increase of 37.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imhotef Pharmaceuticals?
Unlock access to Imhotef Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.30 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2022 | Hdfc Bank Limited | ₹1.30 M | Open |
How Many Employees Work at Imhotef Pharmaceuticals?
Unlock and access historical data on people associated with Imhotef Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imhotef Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imhotef Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.